Baicalein
is an active ingredient extracted from the dried roots
of the Scutellaria baicalensis Georgi. It has been
demonstrated to improve memory impairment in multiple animal models;
however, the underlying mechanisms remain ambiguous. The accumulation
of senescent astrocytes and senescence-associated secretory phenotype
(SASP) secreted by senescent astrocytes has been deemed as potential
contributors to neurodegenerative diseases. Therefore, this study
explored the protective effects of baicalein against astrocyte senescence
and investigated the molecular mechanisms and metabolic mechanisms
of baicalein against astrocyte senescence. Our results demonstrated
that treatment with baicalein protects T98G cells from H2O2-induced damage, delays cell senescence, inhibits the
secretion of SASP (IL-6, IL-8, TNF-α, CXCL1, and MMP-1), and
inhibits SASP-related pathways NF-κB and JAK2/STAT1. 1H NMR metabolomics analysis and correlation analysis revealed that
leucine was significantly correlated with SASP factors. Further study
demonstrated that supplement with leucine could restrain SASP secretion,
and baicalein could significantly increase leucine level through down-regulation
of BCAT1 and up-regulation of SLC7A5 expression. The above results
revealed that baicalein exerted protective and antisenescence effects
in H2O2-induced T98G cells possibly through
inhibition of SASP, suppression of JAK2/STAT1/NF-κB pathway,
and regulation of leucine metabolism. Consistent results were obtained
in primary astrocytes of newborn SD rats, which suggests that baicalein
significantly increases viabilities, delays senescence, inhibits IL-6
secretion, and increases leucine level in H2O2-induced primary astrocytes.